Multifocal Motor Neuropathy

Clinical trial on MMN ongoing at the Institute:

  • ARGX-117-2002_ARDA: A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy.



Intervention ARGX-117
Principal investigator K. Viala
Sponsor Argenx
Study status Ongoing
Recruitment status In preparation
Population Adult
+ infos on